Mahesh Pandit

Gyeongsan-si, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Nanoparticle-based methionine and AICAR delivery elicits a robust antitumor immune response.

Nanoparticle-based methionine and AICAR delivery elicits a robust antitumor immune response.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: January 21, 2025

Methionine consumption by cancer cells drives a progressive upregulation of PD-1 expression in CD4 T cells.

Methionine consumption by cancer cells drives a progressive upregulation of PD-1 expression in CD4 T cells.

Journal: Nature communications

Published: October 26, 2022

Engineering of hybrid spheroids of mesenchymal stem cells and drug depots for immunomodulating effect in islet xenotransplantation.

Engineering of hybrid spheroids of mesenchymal stem cells and drug depots for immunomodulating effect in islet xenotransplantation.

Journal: Science advances

Published: August 24, 2022

Modulation of NLRP3 inflammasomes activation contributes to improved survival and function of mesenchymal stromal cell spheroids.

Modulation of NLRP3 inflammasomes activation contributes to improved survival and function of mesenchymal stromal cell spheroids.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: August 09, 2022

T-cell engaging poly(lactic-co-glycolic acid) nanoparticles as a modular platform to induce a potent cytotoxic immunogenic response against PD-L1 overexpressing cancer.

T-cell engaging poly(lactic-co-glycolic acid) nanoparticles as a modular platform to induce a potent cytotoxic immunogenic response against PD-L1 overexpressing cancer.

Journal: Biomaterials

Published: July 05, 2022

Reactive oxygen species-responsive dual-targeted nanosystem promoted immunogenic cell death against breast cancer.

Reactive oxygen species-responsive dual-targeted nanosystem promoted immunogenic cell death against breast cancer.

Journal: Bioengineering & translational medicine

Published: March 28, 2022

AMPK suppresses Th2 cell responses by repressing mTORC2.

AMPK suppresses Th2 cell responses by repressing mTORC2.

Journal: Experimental & molecular medicine

Published: January 24, 2022

Preparation and evaluation of dabrafenib-loaded, CD47-conjugated human serum albumin-based nanoconstructs for chemoimmunomodulation.

Preparation and evaluation of dabrafenib-loaded, CD47-conjugated human serum albumin-based nanoconstructs for chemoimmunomodulation.

Journal: Colloids and surfaces. B, Biointerfaces

Published: June 24, 2021

Combination chemotherapeutic and immune-therapeutic anticancer approach via anti-PD-L1 antibody conjugated albumin nanoparticles.

Combination chemotherapeutic and immune-therapeutic anticancer approach via anti-PD-L1 antibody conjugated albumin nanoparticles.

Journal: International journal of pharmaceutics

Published: April 21, 2021

AMPK promotes antitumor immunity by downregulating PD-1 in regulatory T cells via the HMGCR/p38 signaling pathway.

AMPK promotes antitumor immunity by downregulating PD-1 in regulatory T cells via the HMGCR/p38 signaling pathway.

Journal: Molecular cancer

Published: April 19, 2021

Geranylgeranyl pyrophosphate amplifies Treg differentiation via increased IL-2 expression to ameliorate DSS-induced colitis.

Geranylgeranyl pyrophosphate amplifies Treg differentiation via increased IL-2 expression to ameliorate DSS-induced colitis.

Journal: European journal of immunology

Published: September 23, 2020

LKB1-PTEN axis controls Th1 and Th17 cell differentiation via regulating mTORC1.

LKB1-PTEN axis controls Th1 and Th17 cell differentiation via regulating mTORC1.

Journal: Journal of molecular medicine (Berlin, Germany)

Published: August 18, 2020

Showing 1-12 of 13

Last Updated: 09/26/2026